HYFC TECHNOLOGY - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79232578
Serial Number
79232578
Registration Number
5736165
Word Mark
HYFC TECHNOLOGY
Status
700 - Registered
Status Date
2019-04-30
Filing Date
2018-02-28
Registration Number
5736165
Registration Date
2019-04-30
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260314, 260321 - Three or more ovals. Ovals that are completely or partially shaded.
Published for Opposition Date
2019-02-12
Law Office Assigned Location Code
L40
Employee Name
EISNACH, MICHAEL PATRI
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"TECHNOLOGY"
Description of Mark
The mark consists of a stylized design consisting of two ovals connected by 5 lines to two more ovals that are divided, and are stacked above two other ovals. To the right of the stylized design are the letters "hyFc" stacked above the word "technology".
Goods and Services
Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for preventing and treating obesity; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for wounds; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of infectious diseases; Synthetic peptides for pharmaceutical purposes for treating hypertension; Synthetic peptides for pharmaceutical purposes for the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of hormonal disorders and the prevention of osteoporosis; Synthetic peptides for pharmaceutical purposes for the treatment of eye diseases and conditions; Synthetic peptides for pharmaceutical purposes for the treatment of multiple sclerosis; Synthetic peptides for pharmaceutical purposes for treating diabetes; Synthetic peptides for pharmaceutical purposes for affecting metabolism; Synthetic peptides for pharmaceutical purposes for regulating the immune system; Synthetic peptides for pharmaceutical purposes for the treatment of viral diseases; Synthetic peptides for pharmaceutical purposes for affecting and treating urogenital organs; Synthetic peptides for pharmaceutical purposes for preventing and treating obesity; Synthetic peptides for pharmaceutical purposes for the treatment of bone diseases; Synthetic peptides for pharmaceutical purposes for wounds; Synthetic peptides for pharmaceutical purposes for activating cellular function; Synthetic peptides for pharmaceutical purposes for affecting digestive organs; Synthetic peptides for pharmaceutical purposes for the treatment of cardiovascular disease; Synthetic peptides for pharmaceutical purposes for treating malignant tumours; Synthetic peptides for pharmaceutical purposes for the treatment and prevention of cancer; Synthetic peptides for pharmaceutical purposes for treatment of viral and infectious diseases, for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of cancer; Synthetic peptides for pharmaceutical purposes for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of auto-immune diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-06-01
Primary Code
005
Current Trademark Owners
Party Name
Genexine, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Genexine, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Genexine, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Genexine, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
ERUUM & LEEON
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1403018
International Registration Date
2018-02-28
International Publication Date
2018-05-24
International Renewal Date
2028-02-28
Auto Protection Date
2019-11-24
International Status
001 - Request for extension of protection established
International Status Date
2018-05-24
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2018-05-24SN ASSIGNED FOR SECT 66A APPL FROM IB
2018-06-01NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-06-05APPLICATION FILING RECEIPT MAILED
2018-06-12ASSIGNED TO EXAMINER
2018-06-19NON-FINAL ACTION WRITTEN
2018-06-20NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-06-28REFUSAL PROCESSED BY MPU
2018-06-28NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2018-07-14REFUSAL PROCESSED BY IB
2018-12-27TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-12-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-12-27TEAS/EMAIL CORRESPONDENCE ENTERED
2018-12-28APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-27TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-01-23NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-01-23NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2019-01-23NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2019-02-08NOTIFICATION PROCESSED BY IB
2019-02-12PUBLISHED FOR OPPOSITION
2019-02-12OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-04-30REGISTERED-PRINCIPAL REGISTER
2019-05-13TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-07-30FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2019-08-24FINAL DISPOSITION PROCESSED
2019-08-24FINAL DISPOSITION NOTICE SENT TO IB
2019-09-13FINAL DECISION TRANSACTION PROCESSED BY IB
2020-05-28NEW REPRESENTATIVE AT IB RECEIVED